MedPath
NMPA Approval

Levetiracetam Oral Solution

国药准字H20244777

September 3, 2024

Drug Information

左乙拉西坦口服溶液

口服溶液剂

100ml:10g

化学药品

September 3, 2024

Company Information

Applicant Company

北京市大兴区天富街9号10幢2层215室

Manufacturing Company

北京市顺义区中北工业区(北石槽镇)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

左乙拉西坦口服溶液 - NMPA 批准文号 | MedPath